Dihydroquercetin as potential immunonutrient in treatment of COVID-19
В. В. Татаринов, Светлана Владимировна Орлова, Елена Александровна Никитина, E. V. Prokopenko, A. N. Vodolazkaya, Yu. A. Pigareva, K. V. Paliy · Medical alphabet · 2021
The main aspects of the antiviral, anti-inflammatory, antioxidant and hepatoprotective properties of dihydroquercetin (DHQ), which may affect the course of COVID-19, are considered. Given the low toxicity and a wide range of biological activity, aimed not only at suppressing enzymatic reactions with the participation of coronavirus, but also at eliminating the lesions caused by it in all the main target organs, dihydroquercetin can be recommended for inclusion in the complex therapy of the disease and during the recovery period of COVID-19.